Initial Events in Human Ocular Toxoplasmosis
Initial Events in Human Ocular Toxoplasmosis
批准号:
7911724
负责人:
JUSTINE R SMITH
金额:
$23.1万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2012-08-31
关键词:
AddressAdultAdverse effectsAffectAfricaAreaAttentionBehaviorBindingBiological AssayBiologyBloodCell Adhesion MoleculesCell surfaceCellsCentral Nervous System PartChildChorioretinitisChoroidClinicalCollaborationsDataDevelopmentDiseaseEndothelial CellsEndotheliumEpidemiologyEuropeEventEyeEye InfectionsEye diseasesGeneticGenotypeGrowthHandHaplogroupHousingHumanHuman DevelopmentImmune responseImmunocompetentImmunocompromised HostImmunologyIn VitroIndividualInfectionInflammatoryInvestigationKnowledgeLaboratoriesLeukocytesMethodologyMigration AssayModelingMononuclearMovementMusMyocardiumNorth AmericaOcular ToxoplasmosisOutcomeParasitesParasitic Eye InfectionsPatientsPharmaceutical PreparationsPopulationPredispositionReagentResearchRetinaRetinalSeveritiesSouth AmericaStreamSystemic infectionTestingTissuesToxoplasma gondiiToxoplasmosisUniversitiesVascular EndotheliumVirulenceVirulentVisionVisual impairmentWashingtonWorkantimicrobialbaseeffective therapygenetic manipulationmonocytenovelparasite genomepublic health relevanceresearch studyresponseretina blood vessel structureretina circulationskeletaltranslational approachunborn child
中文摘要
描述(申请人提供):眼弓形体病是一种由弓形虫寄生虫感染引起的炎症性眼病。仅在美国,估计就有超过125万人患有这种疾病。在其他方面健康的成年人中,他们是受弓形虫病影响的最大群体,永久性视力损害是一种常见的结果。尤其是侵袭性疾病发生在免疫功能受损的个人和先天性感染的儿童中。抗菌治疗可能会抑制寄生虫的生长,但副作用很常见,而且没有任何药物可以根除眼组织中包囊的寄生虫。这项工作的总体目标是了解在建立眼弓形体病期间在人眼中运行的基本机制。虽然在弓形虫生物学领域已经取得了相当大的进展,但与人类眼部感染机制有关的基本问题仍然没有得到回答。重要的是,目前尚不清楚弓形虫是如何通过血液进入人眼的。此外,目前还不清楚人类眼睛内的哪些细胞群体优先感染这种寄生虫。最后,没有关于寄生虫基因对这些事件的影响的信息。该项目基于这样的假设,即不同品系的寄生虫与眼睛细胞和组织的相互作用不同。弓形虫或寄生的单核细胞与人眼血管内皮细胞结合和迁移的能力将分别使用体外和体外结合试验和Transwell迁移试验进行评估。将研究游离寄生虫在新鲜人眼组织中的移动,并将使用分离的视网膜培养来确定不同眼细胞对感染的敏感性。选定的弓形虫菌株将进行比较,以确定寄生虫遗传学对眼睛弓形虫病发病时发生在人眼中的事件的影响。与公共卫生相关:眼弓形体病是一种威胁视力的寄生性眼部感染,在美国很常见。没有任何治疗方法可以治愈这种疾病。这项工作将描述感染开始时眼睛中发生的事件,这是朝着开发更有效的治疗这种疾病的患者迈出的重要的第一步。
英文摘要
DESCRIPTION (provided by applicant): Ocular toxoplasmosis is an inflammatory eye disease caused by infection with the parasite, Toxoplasma gondii. In the US alone, this condition is estimated to affect over 1.25 million individuals. In otherwise healthy adults, who constitute the largest group affected by ocular toxoplasmosis, permanent visual impairment is a common outcome. Particularly aggressive disease is observed in immunocompromised individuals and congenitally infected children. Antimicrobial treatments may suppress growth of the parasite, but side effects are common, and no drug eradicates encysted parasites from the ocular tissues. The overall objective of this work is to understand the basic mechanisms operating in the human eye during establishment of ocular toxoplasmosis. Although there have considerable advances in the field of T. gondii biology, basic questions relating to the mechanisms of human ocular infection remain unanswered. Importantly, it is not known how T. gondii gains access to the human eye from the blood stream. In addition, it is unclear which cell populations within the human eye are preferentially infected by the parasite. Finally, there is no information regarding the impact of parasite genotype on these events. This project is based on the hypothesis that parasites of different strains interact differently with the ocular cells and tissues. The ability of T. gondii or parasitized monocytes to bind to and migrate across human ocular vascular endothelium will be evaluated using in vitro and ex vivo binding assays, and a transwell migration assay, respectively. Movement of free parasites within fresh human ocular tissue will be investigated, and the susceptibility of different ocular cells to infection will be established using dissociated retinal cultures. Selected T. gondii strains will be compared to determine the influence of parasite genetics on the events that occur in the human eye at the onset of ocular toxoplasmosis. PUBLIC HEALTH RELEVANCE: Ocular toxoplasmosis is a vision-threatening parasitic eye infection that is common in the US. No treatment cures the disease. This work will characterize the events occuring in the eye at the onset of the infection, which is an important first step toward the development of more effective treatments for patients with the condition.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Adhesion Molecules in Uveitis
-
批准号:8658500
-
项目类别:
-
资助金额:$22.26万
-
财政年份:2013
-
负责人:JUSTINE R SMITH
-
依托单位:
B Cell Trafficking to the Eye
-
批准号:8675775
-
项目类别:
-
资助金额:$17.84万
-
财政年份:2013
-
负责人:JUSTINE R SMITH
-
依托单位:
B Cell Trafficking to the Eye
-
批准号:8309047
-
项目类别:
-
资助金额:$1.41万
-
财政年份:2011
-
负责人:JUSTINE R SMITH
-
依托单位:
Adhesion Molecules in Uveitis
-
批准号:7765414
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2010
-
负责人:JUSTINE R SMITH
-
依托单位:
Adhesion Molecules in Uveitis
-
批准号:8008781
-
项目类别:
-
资助金额:$29.57万
-
财政年份:2010
-
负责人:JUSTINE R SMITH
-
依托单位:
Adhesion Molecules in Uveitis
-
批准号:8206827
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2010
-
负责人:JUSTINE R SMITH
-
依托单位:
Initial Events in Human Ocular Toxoplasmosis
-
批准号:7638274
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2009
-
负责人:JUSTINE R SMITH
-
依托单位:
Role of Retinal Microvasculature in Posterior Uveitis
-
批准号:6928997
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2003
-
负责人:JUSTINE R SMITH
-
依托单位:
Role of Retinal Microvasculature in Posterior Uveitis
-
批准号:6790630
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:JUSTINE R SMITH
-
依托单位:
Role of Retinal Microvasculature in Posterior Uveitis
-
批准号:6672603
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:JUSTINE R SMITH
-
依托单位:
Role of Retinal Microvasculature in Posterior Uveitis
-
批准号:6950102
-
项目类别:
-
资助金额:$6.19万
-
财政年份:2003
-
负责人:JUSTINE R SMITH
-
依托单位:
Role of Retinal Microvasculature in Posterior Uveitis
-
批准号:7087696
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2003
-
负责人:JUSTINE R SMITH
-
依托单位:
海外基金